Does MOLSIDOMINE Cause Lymphopenia? 17 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Lymphopenia have been filed in association with MOLSIDOMINE. This represents 4.4% of all adverse event reports for MOLSIDOMINE.
17
Reports of Lymphopenia with MOLSIDOMINE
4.4%
of all MOLSIDOMINE reports
17
Deaths
17
Hospitalizations
How Dangerous Is Lymphopenia From MOLSIDOMINE?
Of the 17 reports, 17 (100.0%) resulted in death, 17 (100.0%) required hospitalization, and 17 (100.0%) were considered life-threatening.
Is Lymphopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOLSIDOMINE. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does MOLSIDOMINE Cause?
Toxic epidermal necrolysis (84)
Blister (54)
Erythema (53)
Nausea (48)
Multiple organ dysfunction syndrome (45)
Respiratory disorder (44)
Diarrhoea (41)
Hypertension (37)
Cholecystitis (36)
Electrolyte imbalance (36)
What Other Drugs Cause Lymphopenia?
FINGOLIMOD (1,515)
CYCLOPHOSPHAMIDE (952)
RITUXIMAB (932)
DEXAMETHASONE (814)
PREDNISONE (788)
DIMETHYL (598)
METHOTREXATE (549)
PREDNISOLONE (465)
TACROLIMUS (456)
MYCOPHENOLATE MOFETIL (453)
Which MOLSIDOMINE Alternatives Have Lower Lymphopenia Risk?
MOLSIDOMINE vs MOMELOTINIB
MOLSIDOMINE vs MOMETASONE
MOLSIDOMINE vs MOMETASONE FUROATE
MOLSIDOMINE vs MOMETASONE FUROATE\OLOPATADINE
MOLSIDOMINE vs MONOMETHYL